473 related articles for article (PubMed ID: 26884398)
1. Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle.
Farini A; Sitzia C; Cassinelli L; Colleoni F; Parolini D; Giovanella U; Maciotta S; Colombo A; Meregalli M; Torrente Y
Development; 2016 Feb; 143(4):658-69. PubMed ID: 26884398
[TBL] [Abstract][Full Text] [Related]
2. New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD.
Constantin B; Sebille S; Cognard C
J Muscle Res Cell Motil; 2006; 27(5-7):375-86. PubMed ID: 16897576
[TBL] [Abstract][Full Text] [Related]
3. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.
Meyer P; Notarnicola C; Meli AC; Matecki S; Hugon G; Salvador J; Khalil M; Féasson L; Cances C; Cottalorda J; Desguerre I; Cuisset JM; Sabouraud P; Lacampagne A; Chevassus H; Rivier F; Carnac G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884796
[TBL] [Abstract][Full Text] [Related]
4. IP
Valladares D; Utreras-Mendoza Y; Campos C; Morales C; Diaz-Vegas A; Contreras-Ferrat A; Westermeier F; Jaimovich E; Marchi S; Pinton P; Lavandero S
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3685-3695. PubMed ID: 30251688
[TBL] [Abstract][Full Text] [Related]
5. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy.
Claflin DR; Brooks SV
Am J Physiol Cell Physiol; 2008 Feb; 294(2):C651-8. PubMed ID: 18171725
[TBL] [Abstract][Full Text] [Related]
6. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
7. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
8. Mini-dystrophin expression down-regulates overactivation of G protein-mediated IP3 signaling pathway in dystrophin-deficient muscle cells.
Balghi H; Sebille S; Constantin B; Patri S; Thoreau V; Mondin L; Mok E; Kitzis A; Raymond G; Cognard C
J Gen Physiol; 2006 Feb; 127(2):171-82. PubMed ID: 16446505
[TBL] [Abstract][Full Text] [Related]
9. Total Absence of Dystrophin Expression Exacerbates Ectopic Myofiber Calcification and Fibrosis and Alters Macrophage Infiltration Patterns.
Young CNJ; Gosselin MRF; Rumney R; Oksiejuk A; Chira N; Bozycki L; Matryba P; Łukasiewicz K; Kao AP; Dunlop J; Robson SC; Zabłocki K; Górecki DC
Am J Pathol; 2020 Jan; 190(1):190-205. PubMed ID: 31726040
[TBL] [Abstract][Full Text] [Related]
10. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.
Pritchard HAT; Pires PW; Yamasaki E; Thakore P; Earley S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9745-E9752. PubMed ID: 30181262
[TBL] [Abstract][Full Text] [Related]
13. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
14. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.
Kumar A; Boriek AM
FASEB J; 2003 Mar; 17(3):386-96. PubMed ID: 12631578
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.
Alexander MS; Casar JC; Motohashi N; Vieira NM; Eisenberg I; Marshall JL; Gasperini MJ; Lek A; Myers JA; Estrella EA; Kang PB; Shapiro F; Rahimov F; Kawahara G; Widrick JJ; Kunkel LM
J Clin Invest; 2014 Jun; 124(6):2651-67. PubMed ID: 24789910
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes.
Basset O; Boittin FX; Cognard C; Constantin B; Ruegg UT
Biochem J; 2006 Apr; 395(2):267-76. PubMed ID: 16393138
[TBL] [Abstract][Full Text] [Related]
18. Intestine of dystrophic mice presents enhanced contractile resistance to stretching despite morphological impairment.
Alves GA; Silva LR; Rosa EF; Aboulafia J; Freymüller-Haapalainen E; Souccar C; Nouailhetas VL
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G191-9. PubMed ID: 24284964
[TBL] [Abstract][Full Text] [Related]
19. Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines.
Liberona JL; Powell JA; Shenoi S; Petherbridge L; Caviedes R; Jaimovich E
Muscle Nerve; 1998 Jul; 21(7):902-9. PubMed ID: 9626250
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
Ruegg UT; Nicolas-Métral V; Challet C; Bernard-Hélary K; Dorchies OM; Wagner S; Buetler TM
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S155-61. PubMed ID: 12206810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
